| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 62596 |
cas:1116086-09-9，Fmoc-Phe -Lys(Trt)-PAB-PNP， ADC试剂 |
66 |
kx |
2024-12-19 |
| 62597 |
N3-C5-NHS ester CAS:866363-70-4 |
74 |
zyl |
2024-12-19 |
| 62598 |
CAS号：2055024-54-7，化合物：Boc-PEG4-Val-Cit-PAB-OH，叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
73 |
WYQ |
2024-12-19 |
| 62599 |
DOTA-DPhe1-Tyr3-octreotide DOTA-DPhe 1-Tyr 3-奥曲肽 |
70 |
h |
2024-12-19 |
| 62600 |
CAS号：870487-10-8，化合物：Boc-Val-Cit-PAB-PNP |
66 |
WYQ |
2024-12-19 |
| 62601 |
DOTA-PESIN 金属螯合剂DOTA偶联多肽 |
69 |
h |
2024-12-19 |
| 62602 |
(Ac)Phe-Lys(Alloc)-PABC-PNP， ADC试剂 |
61 |
kx |
2024-12-19 |
| 62603 |
Mal-PEG8-Val-Cit-PAB-PNP，C47H67N9O19 |
120 |
WYQ |
2024-12-19 |
| 62604 |
DBCO-PEG3-Val-Cit-PAB-PNP，ADC定制 |
70 |
wyh |
2024-12-19 |
| 62605 |
[d-Phe7]-α-MSH3-10 |
87 |
h |
2024-12-19 |
| 62606 |
cas:863971-53-3，Fmoc-Val-Cit-PAB-PNP， ADC试剂 |
90 |
kx |
2024-12-19 |
| 62607 |
CAS: 2055041-37-5， Mal-PEG1-Val-Cit-PAB-OH（有时也被称为Mal-PEG1-Val-Cit-PABC-OH） |
64 |
WYQ |
2024-12-19 |
| 62608 |
Mal-L-PA-NH-Boc CAS:1491152-23-8 |
66 |
zyl |
2024-12-19 |
| 62609 |
cas:2504147-53-7 ，Mal-amido-PEG2-Val-Cit-PAB-OH，ADC定制 |
62 |
wyh |
2024-12-19 |
| 62610 |
Mal-PEG1-Val-Cit-OH，马来酰亚胺-一聚乙二醇-VAL-CIT-羟基 |
69 |
WYQ |
2024-12-19 |
| 62611 |
cas:1342820-51-2，SGD-1910， ADC试剂 |
93 |
kx |
2024-12-19 |
| 62612 |
Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 |
79 |
zyl |
2024-12-19 |
| 62613 |
cas:1228105-52-9，DM4-SMCC， ADC试剂 |
91 |
kx |
2024-12-19 |
| 62614 |
马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯，ADC定制 |
70 |
wyh |
2024-12-19 |
| 62615 |
cas:863971-56-6，Val-Cit-PAB-MMAF， ADC试剂 |
62 |
kx |
2024-12-19 |
| 62616 |
SPDMB CAS:2101206-29-3合成方法 |
80 |
zyl |
2024-12-19 |
| 62617 |
cas:2055041-39-7，Mal-PEG4-Val-Cit-PAB-OH，ADC定制 |
74 |
wyh |
2024-12-19 |
| 62618 |
cas:1347750-81-5，Mal-NH-PEG2-CH2CH2COOPFP ester， ADC试剂 |
73 |
kx |
2024-12-19 |
| 62619 |
金属螯合剂DOTA偶联α-MSH八肽类似物 |
56 |
h |
2024-12-19 |
| 62620 |
cas:1286715-33-0，2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate |
93 |
kx |
2024-12-19 |
| 62621 |
DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 |
60 |
h |
2024-12-19 |
| 62622 |
Azidoethyl-SS-ethylazide CAS:352305-38-5 |
70 |
zyl |
2024-12-19 |
| 62623 |
CAS: 870487-09-5， Boc-Val-Cit-PAB |
73 |
WYQ |
2024-12-19 |
| 62624 |
cas:2101206-67-9，Ald-Ph-amido-PEG1-C2-Pfp ester， ADC试剂 |
64 |
kx |
2024-12-19 |
| 62625 |
Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 |
85 |
zyl |
2024-12-19 |
| 62626 |
HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA |
79 |
h |
2024-12-19 |
| 62627 |
cas:1222787-24-7，2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate |
195 |
kx |
2024-12-19 |
| 62628 |
Tr-PEG5-OH CAS:141282-24-8物理化学性质 |
85 |
zyl |
2024-12-19 |
| 62629 |
CAS: 870487-08-4，Boc-Val-Cit，(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
87 |
WYQ |
2024-12-19 |
| 62630 |
DOTA-8-Aoc-BBN[7-14]NH |
95 |
h |
2024-12-19 |
| 62631 |
Fmoc-PEG3-Val-Cit，N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
74 |
WYQ |
2024-12-19 |
| 62632 |
CAS: 2226472-28-0，DBCO-PEG4-Val-Cit-PAB-PNP |
74 |
WYQ |
2024-12-19 |
| 62633 |
CAS: 2055024-64-9，Azido-PEG4-Val-Cit-PAB-OH |
74 |
WYQ |
2024-12-19 |
| 62634 |
CAS: 870487-09-5，Boc-Val-Cit-PAB |
79 |
WYQ |
2024-12-19 |
| 62635 |
CAS:784105-33-5 Amino-PEG3-C2-acid的介绍 |
68 |
zyl |
2024-12-19 |
| 62636 |
CAS 863971-53-3：Fmoc-Val-Cit-PAB-PNP |
82 |
WYQ |
2024-12-19 |
| 62637 |
Ald-Ph-amido-PEG11-C2-NH2 CAS:1337889-01-6 |
65 |
zyl |
2024-12-19 |
| 62638 |
cas:2003260-13-5 ， MA-PEG4-Ala-Ala-PAB-PNP，ADC定制 |
68 |
wyh |
2024-12-19 |
| 62639 |
DOTA-NCS-6-Ahx-Phe 19-ST[1-19] DOTA偶联ST肽类似物 |
94 |
h |
2024-12-19 |
| 62640 |
1,4,7,10-四氮杂-n-(1-羧基-3-(4-硝基苯基)丙基)-n,N , N ‴-tris(acetic酸)环十二烷(PA-DOTA) |
62 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询